Elanco/Bayer crosses finish line with FTC clearance
The Federal Trade Commission has conditionally approved Elanco’s $7.6 billion purchase of Bayer’s animal health business, granting the final antitrust clearance the companies needed to close the deal.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10